secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0000950170-23-001185
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics issues 237,804 more shares through partial IPO over-allotment exercise
--------------------------------------------------------------------------------

- Sold 237,804 shares of common stock and warrants for 145,000 shares upon partial over-allotment exercise, closing January 25, 2023.
- Total offering: 3,287,804 shares and warrants for 1,670,000 shares; gross proceeds of approx. $16.4 million.
- Issued underwriters an additional five-year warrant to purchase 16,646 shares at $6.25 per share.
- Chardan Capital Markets and Newbridge Securities acted as joint book-running managers; Joseph Gunnar as co-manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000095017023001185/0000950170-23-001185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000095017023001185/coya-20230125.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-001185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer